Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome

OBJECTIVE: To assess outcomes of repeat rituximab cycles and identify predictors of sustained clinical response in systemic manifestations of primary Sjögren syndrome (pSS). METHODS: An observational study was conducted in 40 rituximab‐treated patients with pSS. Clinical response was defined as a 3‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepple, Sophanit, Arnold, Jack, Vital, Edward M., Rawstron, Andrew C., Pease, Colin T., Dass, Shouvik, Emery, Paul, Md Yusof, Md Yuzaiful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374056/
https://www.ncbi.nlm.nih.gov/pubmed/35666029
http://dx.doi.org/10.1002/acr2.11466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374056/
https://www.ncbi.nlm.nih.gov/pubmed/35666029
http://dx.doi.org/10.1002/acr2.11466

Ejemplares similares